Briefly, in vitro fertilization treatment can be termed fertilization of female and male reproductive cells in extracorporeal conditions.
In IVF treatment, male and female reproductive cells are kept in a suitable environment at body temperature for 48 hours. Fertilization occurs in about half of the eggs obtained during this period. These fertilized eggs are called the embryo (fetus) and the final target is placed in the woman’s uterus.
The embryos are placed into the uterus through a thin catheter (embryo transfer) from the cervix. The pregnancy occurs in approximately 50% of the women after these procedures. However, some of these pregnancies end with abortion. Approximately 40% of the couples entering treatment receive their children. This ratio can be as high as 70-80% for many applications. The remaining 20-30% can not have children today despite all the possibilities of modern medicine.
In vitro fertilization therapy is given to stimulate the ovaries of the woman with various medicines (Gonal-F, Puregon, Menopur, Fostimon)
In vitro fertilization is a treatment applied to women who can not conceive with classical methods. Embryos formed as a result of combining male (sperm) and female (egg) progeny cells under laboratory conditions are based on the principle of transfer of the uterus. Fertilization performed under laboratory conditions is achieved either by spontaneous (in vitro fertilization) or by single hand administration of the human sperm into the single egg (microinjection).